biostudies-otherSevergnini M43-56https://www.ebi.ac.uk/biostudies/studies/S-ECPF-MEXP-232EurocanPlatformEvaluation of two commercial microarray platforms (Amersham CodeLink UniSet Human 10K I BioArray and Affymetrix GeneChip HG-U133A). Both platforms have been tested on gene expression profiling of MDA-MB-231 human metastatic breast cancer cells, cultured for 48 h in the absence (control) or presence (treated) of 32 µM resveratrol.biostudies-othertranscription profiling by arrayEurocanPlatformUnknown353Analytical biochemistryHomo sapiensMezzelani APeano CDe Bellis GViti FMilanesi LBicciato SBattaglia CGhidoni RMangano EBonnal RScarlatti FSevergnini MMattioli MfalsePlatform comparison and transcription profiling of MDA-MB-231 human metastatic breast cancer cells, cultured for 48 h in the absence (control) or presence (treated) of 32 ?M resveratrol to evaluate Amersham CodeLink UniSet Human 10K I BioArray and Affymetrix GeneChip HG-U133A)Evaluation of two commercial microarray platforms (Amersham CodeLink UniSet Human 10K I BioArray and Affymetrix GeneChip HG-U133A). Both platforms have been tested on gene expression profiling of MDA-MB-231 human metastatic breast cancer cells, cultured for 48 h in the absence (control) or presence (treated) of 32 µM resveratrol.2016-04-14T14:46:23Z2006 Jun2016-04-14T14:46:23Z2016-04-14T14:46:23ZS-ECPF-MEXP-232E-MEXP-232EFO_0000305EFO_0000322E-MEXP-232